Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation

Molecular Microbiology

Volumn 78, Issue 5, 2010, Pages 1232-1245

  Royan, Sandhya V ^a,b   Jones, Rheinallt M ^c   Koutsouris, Athanasia ^a   Roxas, Jennifer L ^a   Falzari, Kanakeshwari ^a   Weflen, Andrew W ^a   Kim, Amy ^a   Bellmeyer, Amy ^a   Turner, Jerrold R ^d   Neish, Andrew S ^c   Rhee, Ki Jong ^a   Viswanathan, V K ^e   Hecht, Gail A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; BACTERIAL COLONIZATION; CELL STRAIN HEK293; ENTEROPATHOGENIC ESCHERICHIA COLI; GENE; GENE ACTIVATION; GENETIC COMPLEMENTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NLEH1 GENE; NLEH2 GENE; NONHUMAN; PATHOGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM; UBIQUITINATION;

ANIMALS; CELL LINE; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HEK293 CELLS; HUMANS; I-KAPPA B PROTEINS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS; SHIGELLA FLEXNERI;

EID: 78649601848     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2010.07400.x     Document Type: Article

References (50)

1. Angot, A., Vergunst, A., Genin, S., and Peeters, N. (2007) Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 3: e3.
2. Ashida, H., Kim, M., Schmidt-Supprian, M., Ma, A., Ogawa, M., and Sasakawa, C. (2010) A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol 12: 66-73.
3. Chen, H.D., and Frankel, G. (2005) Enteropathogenic Escherichia coli: unravelling pathogenesis. FEMS Microbiol Rev 29: 83-98.
4. Collier-Hyams, L.S., Zeng, H., Sun, J., Tomlinson, A.D., Bao, Z.Q., Chen, H., et al. (2002) Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol 169: 2846-2850.
5. Datsenko, K.A., and Wanner, B.L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
6. Dean, P., and Kenny, B. (2009) The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 12: 101-109.
7. Deng, W., Li, Y., Hardwidge, P.R., Frey, E.A., Pfuetzner, R.A., Lee, S., et al. (2005) Regulation of type III secretion hierarchy of translocators and effectors in attaching and effacing bacterial pathogens. Infect Immun 73: 2135-2146.
8. Dennis, A., Kudo, T., Kruidenier, L., Girard, F., Crepin, V.F., MacDonald, T.T., et al. (2008) The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium. Infect Immun 76: 4978-4988.
9. Elliott, S.J., Sperandio, V., Giron, J.A., Shin, S., Mellies, J.L., Wainwright, L., et al. (2000) The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 68: 6115-6126.
10. Gao, X., Wan, F., Mateo, K., Callegari, E., Wang, D., Deng, W., et al. (2009) Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog 5: e1000708.
11. Garcia-Angulo, V.A., Deng, W., Thomas, N.A., Finlay, B.B., and Puente, J.L. (2008) Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium. J Bacteriol 190: 2388-2399.
12. Haraga, A., and Miller, S.I. (2003) A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-kappa B-dependent gene expression. Infect Immun 71: 4052-4058.
13. Hauf, N., and Chakraborty, T. (2003) Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J Immunol 170: 2074-2082.
14. Hemrajani, C., Marches, O., Wiles, S., Girard, F., Dennis, A., Dziva, F., et al. (2008) Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut. Infect Immun 76: 4804-4813.
15. Hemrajani, C., Berger, C.N., Robinson, K.S., Marches, O., Mousnier, A., and Frankel, G. (2010) NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci USA 107: 3129-3134.
16. Iguchi, A., Thomson, N.R., Ogura, Y., Saunders, D., Ooka, T., Henderson, I.R., et al. (2009) Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. J Bacteriol 191: 347-354.
17. Isberg, R.R., and Normark, S. (2000) Host microbe interactions: bacteria innate immune response: attack and counter-attack. Curr Opin Microbiol 3: 3-13.
18. Jarvis, K.G., Giron, J.A., Jerse, A.E., McDaniel, T.K., Donnenberg, M.S., and Kaper, J.B. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci USA 92: 7996-8000.
19. Jones, R.M., Wu, H., Wentworth, C., Luo, L., Collier-Hyams, L., and Neish, A.S. (2008) Salmonella AvrA coordinates suppression of host immune and apoptotic defenses via JNK pathway blockade. Cell Host Microbe 3: 233-244.
20. Khan, M.A., Bouzari, S., Ma, C., Rosenberger, C.M., Bergstrom, K.S., Gibson, D.L., et al. (2008) Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect Immun 76: 1410-1422.
21. Kim, D.W., Lenzen, G., Page, A.L., Legrain, P., Sansonetti, P.J., and Parsot, C. (2005) The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci USA 102: 14046-14051.
22. Le Negrate, G., Faustin, B., Welsh, K., Loeffler, M., Krajewska, M., Hasegawa, P., et al. (2008) Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol 180: 5045-5056.
23. Li, Q., and Verma, I.M. (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
24. Lira, S.A., Zalamea, P., Heinrich, J.N., Fuentes, M.E., Carrasco, D., Lewin, A.C., et al. (1994) Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med 180: 2039-2048.
25. Loukiadis, E., Nobe, R., Herold, S., Tramuta, C., Ogura, Y., Ooka, T., et al. (2008) Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli. J Bacteriol 190: 275-285.
26. Maresca, M., Miller, D., Quitard, S., Dean, P., and Kenny, B. (2005) Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. Cell Microbiol 7: 1749-1762.
27. Merlin, C., McAteer, S., and Masters, M. (2002) Tools for characterization of Escherichia coli genes of unknown function. J Bacteriol 184: 4573-4581.
28. Mittal, R., Peak-Chew, S.Y., and McMahon, H.T. (2006) Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci USA 103: 18574-18579.
29. Mukherjee, S., and Orth, K. (2008) In vitro signaling by MAPK and NFkappaB pathways inhibited by Yersinia YopJ. Methods Enzymol 438: 343-353.
30. Munro, P., Flatau, G., and Lemichez, E. (2007) Bacteria and the ubiquitin pathway. Curr Opin Microbiol 10: 39-46.
31. Murphy, K.C., and Campellone, K.G. (2003) Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol 4: 11.
32. Nadler, C., Baruch, K., Kobi, S., Mills, E., Haviv, G., Farago, M., et al. (2010) The type III secretion effector NleE inhibits NF-kappaB activation. PLoS Pathog 6: e1000743.
33. Neish, A.S. (2004) Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol Res 29: 175-186.
34. Neurath, M.F., Becker, C., and Barbulescu, K. (1998) Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 43: 856-860.
35. Robinson, K.S., Mousnier, A., Hemrajani, C., Fairweather, N., Berger, C.N., and Frankel, G. (2010) The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B. Microbiology 156: 1815-1823.
36. Ruchaud-Sparagano, M.H., Maresca, M., and Kenny, B. (2007) Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 9: 1909-1921.
37. Savkovic, S.D., Koutsouris, A., and Hecht, G. (1997) Activation of NF-kappaB in intestinal epithelial cells by enteropathogenic Escherichia coli. Am J Physiol 273: C1160-C1167.
38. Savkovic, S.D., Villanueva, J., Turner, J.R., Matkowskyj, K.A., and Hecht, G. (2005) Mouse model of enteropathogenic Escherichia coli infection. Infect Immun 73: 1161-1170.
39. Sha, W.C., Liou, H.C., Tuomanen, E.I., and Baltimore, D. (1995) Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-330.
40. Sharma, R., Tesfay, S., Tomson, F.L., Kanteti, R.P., Viswanathan, V.K., and Hecht, G. (2006) Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 290: G685-G694.
41. Shifflett, D.E., Clayburgh, D.R., Koutsouris, A., Turner, J.R., and Hecht, G.A. (2005) Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab Invest 85: 1308-1324.
42. Simossis, V.A., and Heringa, J. (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res 33: W289-W294.
43. Tani, M., Fuentes, M.E., Peterson, J.W., Trapp, B.D., Durham, S.K., Loy, J.K., et al. (1996) Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest 98: 529-539.
44. Tato, C.M., and Hunter, C.A. (2002) Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun 70: 3311-3317.
45. Taylor, J. (1970) Infectious infantile enterittis, yesterday and today. Proc R Soc Med 63: 1297-1301.
46. Tobe, T., Beatson, S.A., Taniguchi, H., Abe, H., Bailey, C.M., Fivian, A., et al. (2006) An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination. Proc Natl Acad Sci USA 103: 14941-14946.
47. Viswanathan, V.K., Koutsouris, A., Lukic, S., Pilkinton, M., Simonovic, I., Simonovic, M., and Hecht, G. (2004) Comparative analysis of EspF from enteropathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial barrier function. Infect Immun 72: 3218-3227.
48. Wadolkowski, E.A., Burris, J.A., and O'Brien, A.D. (1990) Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58: 2438-2445.
49. Ye, Z., Petrof, E.O., Boone, D., Claud, E.C., and Sun, J. (2007) Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171: 882-892.
50. Zhou, X., Giron, J.A., Torres, A.G., Crawford, J.A., Negrete, E., Vogel, S.N., and Kaper, J.B. (2003) Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect Immun 71: 2120-2129.